Shockwaves induce osteogenic differentiation of human mesenchymal stem cells through ATP release and activation of P2X7 receptors

Stem Cells

Volumn 31, Issue 6, 2013, Pages 1170-1180

  Sun, Dahui ^a   Junger, Wolfgang G ^b,c   Yuan, Changji ^a   Zhang, Wenyan ^a   Bao, Y I ^b   Qin, Daming ^a   Wang, Chengxue ^a   Tan, Lei ^a   Qi, Baochang ^a   Zhu, Dong ^a   Zhang, Xizheng ^d   Yu, Tiecheng ^a  

^a JILIN UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^d BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

ATP; C Fos; C Jun; Human mesenchymal stem cells; Osteogenic differentiation; P38 MAPK; Shockwaves

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; APYRASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; OSTEOCALCIN; PURINERGIC P2 RECEPTOR ANTAGONIST; PURINERGIC P2X7 RECEPTOR; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ADHERENT CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW BIOPSY; BONE MARROW CELL; CELL DAMAGE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; ENZYME PHOSPHORYLATION; EXTRACELLULAR SPACE; FRACTURE; FRACTURE HEALING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MESENCHYMAL STEM CELL; MINERALIZATION; MONONUCLEAR CELL; ONCOGENE C FOS; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PHENOTYPE; PROTEIN EXPRESSION; PSEUDARTHROSIS; SHOCK WAVE; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; APYRASE; BONE MARROW; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; LITHOTRIPSY; MESENCHYMAL STROMAL CELLS; OSTEOCALCIN; OSTEOGENESIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, PURINERGIC P2X7; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84877931876     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1356     Document Type: Article

References (59)

1. Haupt G. Use of extracorporeal shock waves in the treatment of pseudarthrosis, tendinopathy and other orthopedic diseases. J Urol 1997;158:4-11. (Pubitemid 27251584)
2. Wang FS, Wang CJ, Huang HJ et al. Physical shock wave mediates membrane hyperpolarization and Ras activation for osteogenesis in human bone marrow stromal cells. Biochem Biophys Res Commun 2001;287:648-655.
3. Wang FS, Yang KD, Chen RF et al. Extracorporeal shock wave promotes growth and differentiation of bone-marrow stromal cells towards osteoprogenitors associated with induction of TGF-beta1. J Bone Joint Surg Br 2002;84:457-461. (Pubitemid 34413782)
4. Dorotka R, Kubista B, Schatz KD et al. Effects of extracorporeal shock waves on human articular chondrocytes and ovine bone marrow stromal cells in vitro. Arch Orthop Trauma Surg 2003;123:345-348. (Pubitemid 37236197)
5. Burnstock G. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future. Bioessays 2012;34:218-225.
6. Chen Y, Corriden R, Inoue Y et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006;314:1792-1795. (Pubitemid 44969094)
7. Yip L, Woehrle T, Corriden R et al. Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J 2009;23:1685-1693.
8. Junger WG. Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol 2011;11:201-212.
9. Grol MW, Panupinthu N, Korcok J et al. Expression, signaling, and function of P2X7 receptors in bone. Purinergic Signal 2009;5:205-221.
10. Ihara H, Hirukawa K, Goto S et al. ATP-stimulated interleukin-6 synthesis through P2Y receptors on human osteoblasts. Biochem Biophys Res Commun 2005;326:329-334. (Pubitemid 39593550)
11. Katz S, Boland R, Santillan G. Modulation of ERK 1/2 and p38 MAPK signaling pathways by ATP in osteoblasts: Involvement of mechanical stress-activated calcium influx, Pkc and Src activation. Int J Biochem Cell Biol 2006;38:2082-2091. (Pubitemid 44397616)
12. Loomis WH, Namiki S, Ostrom RS et al. Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 Mapk activation. J Biol Chem 2003;278:4590-4596. (Pubitemid 36800956)
13. Yi C, Liu D, Fong CC et al. Gold nanoparticles promote osteogenic differentiation of mesenchymal stem cells through p38 MAPK pathway. Acs Nano 2010;4:6439-6448.
14. Coss D, Hand CM, Yaphockun KK et al. p38 mitogen-activated protein kinase is critical for synergistic induction of the FSH(beta) gene by gonadotropin-releasing hormone and activin through augmentation of c-Fos induction and Smad phosphorylation. Mol Endocrinol 2007;21:3071-3086. (Pubitemid 350223516)
15. Liu WH, Chang LS. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway. J Cell Physiol 2010;224:775-785.
16. Tanaka S, Sakai A, Tanaka M et al. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells. J Bone Miner Res 2004;19:1813-1820. (Pubitemid 41103432)
17. Wu JB, Fong YC, Tsai HY et al. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol 2008;588:333-341.
18. de Freitas PHL, Li M, Ninomiya T et al. Intermittent PTH administration stimulates pre-osteoblastic proliferation without leading to enhanced bone formation in osteoclast-less c-fos(-/-) mice. J Bone Miner Res 2009;24:1586-1597.
19. Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: Quarrel and harmony among siblings. J Cell Sci 2004;117:5965-5973. (Pubitemid 40123963)
20. Neub A, Houdek P, Ohnemus U et al. Biphasic regulation of AP-1 subunits during human epidermal wound healing. J Invest Dermatol 2007;127:2453-2462. (Pubitemid 47619745)
21. Pham DN, Luo H, Wu J. Reduced Ran expression in Ran(+/-) fibroblasts increases cytokine-stimulated nuclear abundance of the AP-1 subunits c-Fos and c-Jun. FEBS Lett 2010;584:4623-4626.
22. Yu T, Junger WG, Yuan C et al. Shockwaves increase T-cell proliferation and IL-2 expression through ATP release, P2X7 receptors, and Fak activation. Am J Physiol Cell Physiol 2010;298:C457-C464.
23. Poulsom R. CD44 and hyaluronan help mesenchymal stem cells move to a neighborhood in need of regeneration. Kidney Int 2007;72:389-390. (Pubitemid 47237618)
24. Trivedi P, Hematti P. Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol 2007;35:146-154. (Pubitemid 46014371)
25. Odabas S, Sayar F, Guven G et al. Separation of mesenchymal stem cells with magnetic nanosorbents carrying CD105 and CD73 antibodies in flow-through and batch systems. J Chromatogr B Analyt Technol Biomed Life Sci 2008;861:74-80. (Pubitemid 50012587)
26. Liu CM, Chang CH, Yu CH et al. Hyaluronan substratum induces multidrug resistance in human mesenchymal stem cells via CD44 signaling. Cell Tissue Res 2009;336:465-475.
27. Hammoud M, Vlaski M, Duchez P et al. Combination of low O(2) concentration and mesenchymal stromal cells during culture of cord blood CD34(+) cells improves the maintenance and proliferative capacity of hematopoietic stem cells. J Cell Physiol 2012;227:2750-2758.
28. Zannettino AC, Paton S, Kortesidis A et al. Human multipotential mesenchymal/stromal stem cells are derived from a discrete subpopulation of STRO-1bright/CD34 /CD45(-)/glycophorin-A-bone marrow cells. Haematologica 2007;92:1707-1708. (Pubitemid 350248254)
29. Di VF, Chiozzi P, Ferrari D et al. Nucleotide receptors: An emerging family of regulatory molecules in blood cells. Blood 2001;97:587-600. (Pubitemid 32113390)
30. Ziganshin AU, Ziganshina LE, King BE et al. Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pflugers Arch 1995;429:412-418.
31. Ohlendorff SD, Tofteng CL, Jensen JE et al. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment. Pharmacogenet Genomics 2007;17:555-567. (Pubitemid 46905222)
32. Li J, Meyer R, Duncan RL et al. P2X7 nucleotide receptor plays an important role in callus remodeling during fracture repair. Calcif Tissue Int 2009;84:405-412.
33. Forte G, Minieri M, Cossa P et al. Hepatocyte growth factor effects on mesenchymal stem cells: Proliferation, migration, and differentiation. Stem Cells 2006;24:23-33.
34. Yew TL, Hung YT, Li HY et al. Enhancement of wound healing by human multipotent stromal cell conditioned medium: The paracrine factors and p38MAPK activation. Cell Transplant 2011;20:693-706.
35. Penolazzi L, Bianchini E, Lambertini E et al. N-Arylpiperazine modified analogues of the P2X7 receptor KN-62 antagonist are potent inducers of apoptosis of human primary osteoclasts. J Biomed Sci 2005;12:1013-1020. (Pubitemid 43081680)
36. Thompson BA, Storm MP, Hewinson J et al. A novel role for P2X7 receptor signalling in the survival of mouse embryonic stem cells. Cell Signal 2012;24:770-778.
37. Ma HZ, Zeng BF, Li XL et al. Temporal and spatial expression of BMP-2 in sub-chondral bone of necrotic femoral heads in rabbits by use of extracorporeal shock waves. Acta Orthop 2008;79:98-105.
38. van der Jagt OP, Piscaer TM, Schaden W et al. Unfocused extracorporeal shock waves induce anabolic effects in rat bone. J Bone Joint Surg Am 2011;93:38-48.
39. Wang CJ, Wang FS, Huang CC et al. Treatment for osteonecrosis of the femoral head: Comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am 2005;87:2380-2387.
40. Kawano S, Otsu K, Kuruma A et al. ATP autocrine/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells. Cell Calcium 2006;39:313-324. (Pubitemid 43286324)
41. Coppi E, Pugliese AM, Urbani S et al. ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. Stem Cells 2007;25:1840-1849. (Pubitemid 47121864)
42. Iu A U, Salmina AB, Malinovskaia NA et al. Features of expression and functional activity of P2X7 receptors in bone marrow cells under the action of doxorubicin. Eksp Klin Farmakol 2007;70:52-56.
43. Chen Y, Hashiguchi N, Yip L et al. Hypertonic saline enhances neutrophil elastase release through activation of P2 and A3 receptors. Am J Physiol Cell Physiol 2006;290:C1051-C1059.
44. Ke HZ, Qi H, Weidema AF et al. Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol 2003;17:1356-1367. (Pubitemid 36819956)
45. Li J, Liu D, Ke HZ et al. The P2X7 nucleotide receptor mediates skeletal mechanotransduction. J Biol Chem 2005;280:42952-42959. (Pubitemid 43049258)
46. Greenblatt MB, Shim JH, Zou W et al. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest 2010;120:2457-2473.
47. Powell JR, Kim DH, Ausubel FM. The G protein-coupled receptor FSHR-1 is required for the Caenorhabditis elegans innate immune response. Proc Natl Acad Sci USA 2009;106:2782-2787.
48. Yamauchi J, Nagao M, Kaziro Y et al. Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gbetagamma and Galphaq/11 subunits. J Biol Chem 1997;272:27771-27777. (Pubitemid 27473576)
49. Ammoun S, Lindholm D, Wootz H et al. G-protein-coupled OX1 orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38 mitogen-/stress-activated protein kinase. J Biol Chem 2006;281:834-842.
50. Glover JN, Harrison SC. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 1995;373:257-261.
51. Surprenant A, Rassendren F, Kawashima E et al. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996;272:735-738.
52. Gunosewoyo H, Coster MJ, Kassiou M. Molecular probes for P2X7 receptor studies. Curr Med Chem 2007;14:1505-1423.
53. Delarasse C, Gonnord P, Galante M et al. Neural progenitor cell death is induced by extracellular ATP via ligation of P2X7 receptor. J Neurochem 2009;109:846-857.
54. Lenertz LY, Gavala ML, Zhu Y et al. Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions. Immunol Res 2011;50:22-38.
55. Panupinthu N, Zhao L, Possmayer F et al. P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J Biol Chem 2007;282:3403-3412. (Pubitemid 47084361)
56. Schleberger R, Senge T. Non-invasive treatment of long-bone pseudarthrosis by shock waves (ESWL). Arch Orthop Trauma Surg 1992;111:224-227.
57. Bara T, Synder M, Studniarek M. The application of shock waves in the treatment of delayed bone union and pseudoarthrosis in long bones. Ortop Traumatol Rehabil 2000;2:54-57.
58. Wang CJ, Chen HS, Chen CE et al. Treatment of nonunions of long bone fractures with shock waves. Clin Orthop Relat Res 2001; 95-101.
59. Panupinthu N, Rogers JT, Zhao L et al. P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: A signaling axis promoting osteogenesis. J Cell Biol 2008;181:859-71. (Pubitemid 351786989)